Stay updated on Savolitinib Combo in EGFRm+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page.

Latest updates to the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedLocations now include California; references to California Locations and Revision: v3.3.2 were removed, with the page upgraded to Revision v3.3.3.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2 with no changes to content, layout, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedAn ancillary funding/status notice related to government operations has been removed; core trial information (title, design, eligibility criteria, locations) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check64 days agoChange DetectedNew Study Record Dates (2025-10-31, 2025-10-28, 2025-10) were added and older dates (2025-07-09, 2025-06-30, 2025-06) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check93 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference2%

- Check100 days agoChange DetectedRemoved several MedlinePlus topics and updated to Revision: v3.1.0, indicating content pruning and version upgrade.SummaryDifference0.4%

Stay in the know with updates to Savolitinib Combo in EGFRm+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page.